Answers are grounded in this paper and cite their sources.
Transnational drug companies are moving their clinical trials business to India, giving a new urgency to clinical trials registry reform there. Patralekha Chatterjee reports.
No takes yet. Share an insight, caveat, or question.
Patralekha Chatterjee (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: